# Amisulpride

## Ribelite 200mg

| TAH Drug Code      | [ORIB](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ORIB)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of psychoses, particularly acute or chronic schizophrenic disorders, characterized by +ve symptoms (e.g. delirium, hallucinations, thought disorders) &/or -ve symptoms (eg blunted emotions, emotional & social withdrawal), including when the -ve symptoms predominate.                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | <=400 mg daily dose, single intake. >400 mg, in 2 divided doses. Predominant negative episode 50-300 mg/day as individualized dosage. Optimum dosage: 100 mg/day. Mixed episodes with positive & negative symptoms 400-800 mg/day as individualized dosage to maintain min effective dose. Acute psychotic episodes: Initiate with maximum 400 mg/day IM, replaced thereafter with 400-800 mg orally, maximum dosage: 1200 mg. Renal insufficiency CrCl 30-60 mL/min: reduce dose to 1/2. CrCl 10-30 mL/min: reduce dose to 1/3.                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Known or suspected pheochromocytoma carriers. Children < 15 years. Lactation. Known or suspected prolactin-dependent tumour, eg prolactin-secreting pituitary adenoma & breast cancer. Severe renal insufficiency. Congenital galactosemia, glucose or galactose malabsorption syndrome or lactase deficiency (due to lactose content). In combination with sultopride; dopaminergic agonists except L-dopa (amantadine, apomorphine, bromocriptine, cabergoline, entacapone, lisuride, pergolide, piribedil, pramipexole, quinagolide, ropinirole, selegiline), except in the case of patients with Parkinson's disease. |
| Adverse Effects    | Common: Hypotension, Injection site pain (6%), Hypokalemia (4%), Prolactin level above reference range (5%), Abdominal distension symptom (2%), Shivering (4%) Serious: Prolonged QT interval                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| More Info          | [UpToDate](https://www.uptodate.com/contents/amisulpride-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

